["{\n\"step_by_step_thinking\": \"The question asks if pneumologists' skepticism about chemotherapy's effectiveness in advanced non-small cell lung carcinoma is justified. From the provided documents, we can see that chemotherapy has shown promise in improving survival rates, especially when combined with other treatments such as surgery or radiation therapy. In fact, a phase III trial showed that combination chemotherapy with mitomycin-C/vindesine plus lonidamine could prolong survival significantly without severe toxicity. Additionally, neoadjuvant chemotherapy has also been shown to improve resection rate and survival in stage III patients. Given these findings, it seems that pneumologists' skepticism may not be entirely justified.\",\n\"answer_choice\": \"B\""]